Tesamorelin / CJC / IPA Blend is a three-peptide blend containing tesamorelin, CJC-1295, and ipamorelin intended for controlled laboratory work. It is studied in experimental systems involving multi-ligand GHRH- and ghrelin-receptor pathway models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.
Research areas include:
• Tesamorelin and CJC-related GHRH signaling
• Ipamorelin-related GHS-R1a signaling
• GH/IGF-1 and metabolic biomarker models
• Three-component compatibility and stability testing
Research limitations and safety:
• Blend names and ratios are not standardized. Every formulation requires explicit ingredient amounts plus independent identity, purity, compatibility, and stability verification. Published or regulatory sources identify material safety uncertainties or adverse signals requiring particular caution.
• No dosing, administration, or therapeutic-use guidance is provided.
being sold for research only.





Reviews
There are no reviews yet.